AU7706000A - Drug target isogenes: polymorphisms in the interleukin-1 beta gene - Google Patents

Drug target isogenes: polymorphisms in the interleukin-1 beta gene

Info

Publication number
AU7706000A
AU7706000A AU77060/00A AU7706000A AU7706000A AU 7706000 A AU7706000 A AU 7706000A AU 77060/00 A AU77060/00 A AU 77060/00A AU 7706000 A AU7706000 A AU 7706000A AU 7706000 A AU7706000 A AU 7706000A
Authority
AU
Australia
Prior art keywords
polymorphisms
interleukin
drug target
beta gene
isogenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77060/00A
Inventor
Anne Chew
Julie . Choi
R. Rex Denton
Krishnan Nandabalan
Joel Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU7706000A publication Critical patent/AU7706000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU77060/00A 1999-09-22 2000-09-20 Drug target isogenes: polymorphisms in the interleukin-1 beta gene Abandoned AU7706000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15541299P 1999-09-22 1999-09-22
US60155412 1999-09-22
PCT/US2000/025794 WO2001021639A1 (en) 1999-09-22 2000-09-20 Drug target isogenes: polymorphisms in the interleukin-1 beta gene

Publications (1)

Publication Number Publication Date
AU7706000A true AU7706000A (en) 2001-04-24

Family

ID=22555317

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77060/00A Abandoned AU7706000A (en) 1999-09-22 2000-09-20 Drug target isogenes: polymorphisms in the interleukin-1 beta gene

Country Status (2)

Country Link
AU (1) AU7706000A (en)
WO (1) WO2001021639A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU760856B2 (en) * 1997-05-29 2003-05-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for chronic obstructive airway disease
WO1999006426A1 (en) * 1997-08-04 1999-02-11 Millennium Biotherapeutics, Inc. Novel molecules of the tango-77 related protein family and uses thereof

Also Published As

Publication number Publication date
WO2001021639A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
AUPQ262599A0 (en) Gene expression
AU3178200A (en) Genetic analysis
AU7119400A (en) Single nucleotide polymorphisms in genes
AU6492400A (en) Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene
AU2000263446A1 (en) Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene
AU2732000A (en) Reverse gene therapy
AU2153401A (en) Gene expression in biological conditions
AU6110700A (en) Drug target isogenes: polymorphisms in the dopamine receptor d2 gene
AU6859500A (en) Plant gene
AU2258601A (en) Ibd-related polymorphisms
AU6343400A (en) Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
AU7706000A (en) Drug target isogenes: polymorphisms in the interleukin-1 beta gene
AU5016200A (en) Diabetes gene
AU1081401A (en) Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene
AU7388700A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene
AU1773501A (en) Human single nucleotide polymorphisms
AU6755300A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
AU1870000A (en) Gene therapy-2
AU6871900A (en) Tsg-like gene
AU4808200A (en) Dna balls
AU5088600A (en) Gene therapy products
GB9921239D0 (en) Plant resistance gene
AU6904100A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene
AU5476600A (en) Gene specific arrays and the use thereof
AU2000277254A1 (en) Drug target isogenes: polymorphisms in the interleukin-4 gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase